This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Eric Yang - Innovator in Blood Substitute Technology
Introduction
Eric Yang is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of medical technology, particularly in the development of blood substitutes. His innovative work aims to enhance the safety and efficacy of blood transfusions.
Latest Patents
Eric Yang holds a patent for his invention titled "Blood substitutes and uses thereof." This invention relates to blood substitute compositions and methods of use. The patent describes compositions in which hemoglobin is maintained substantially in the reduced form, as opposed to the oxidized methemoglobin form. This is achieved through the inclusion of an oxido-reductase enzyme and reducing agent within a vesicle containing the hemoglobin. The vesicles can also comprise a dismutase, a catalase, and an electron acceptor, each contributing to the maintenance of hemoglobin in its active oxygen-carrying state or providing benefits not achievable with free hemoglobin. He has 1 patent to his name.
Career Highlights
Eric Yang is associated with The General Hospital Corporation, where he continues to work on innovative medical solutions. His research focuses on improving blood substitute technologies, which have the potential to save lives and improve patient outcomes.
Collaborations
Eric collaborates with notable colleagues, including Erkin Seker and Tali Konry. Their combined expertise contributes to the advancement of research in blood substitutes and related fields.
Conclusion
Eric Yang's contributions to blood substitute technology represent a significant advancement in medical science. His innovative approach to maintaining hemoglobin in its active form could revolutionize blood transfusion practices.